Weekly posts on small and mid-cap biotech stocks. 100% independent and reader supported with no company sponsored content or hedge fund compensation of any kind. See free performance posts for more information. Not financial advice, for research purposes.
| Platform |  | Pricing | Freemium | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 99 | Founded | 5 years ago | Last Issue | 7 days ago |
| Active | |||||
Read this Newsletter
mattbiotech.substack.comLatest Issues
Harrow Primed For Major Reversal In Next Nine Months: Here's Why
In the next nine months I expect the sentiment around Harrow to completely reverse as the company exceeds both their own guidance and analyst consensus estimates.
Word Count: 5,773 words, Reading Time: 26 minutes. Not financial advice, do...
An All-Encompassing Earnings Update
Companies covered: EOLS, IDYA, GERN, TGTX, TARS, DCTH, XERS, CRNX, CGEM, HROW.
Word Count: 3,108 words, Reading Time: 15 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.
No Need To Rush Into Fulcrum Therapeutics But It Has Potential
Fulcrum's Sickle Cell Disease drug has intriguing early biomarker and efficacy data but long-term safety is an unknown. However it's worth being familiar into 2027 and beyond.
Word Count: 2,606 words, Reading Time: 12 minutes. Not financia...
The Four Pillars For My Portfolio In 2026
The stocks I trust over the next nine months, regardless of geopolitics.
Word Count: 2,582 words, Reading Time: 12 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.
I Was Early Before But Now Is The Time For TG Therapeutics
Word Count: 3,367 words, Reading Time: 15 minutes.
Word Count: 3,367 words, Reading Time: 15 minutes. Not financial advice, do your own due diligence, for entertainment purposes only.
Audience Metrics
Subscribers, engagement, traffic and sponsorship for Matt Gamber’s Biotech Newsletter.
| Subscribers | Engagement | 72 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #122 |
Authors
The writers behind this newsletter.
Social
Frequently Asked Questions
How can I access the email archive for Matt Gamber’s Biotech Newsletter?
You can find recent issues that have been published by Matt Gamber’s Biotech Newsletter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does Matt Gamber’s Biotech Newsletter have?
To see how many people subscribe to Matt Gamber’s Biotech Newsletter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in Matt Gamber’s Biotech Newsletter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch Matt Gamber’s Biotech Newsletter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like Matt Gamber’s Biotech Newsletter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact Matt Gamber’s Biotech Newsletter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to Matt Gamber’s Biotech Newsletter?
Scroll up to where it says Related Newsletters to see other publications like Matt Gamber’s Biotech Newsletter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact Matt Gamber’s Biotech Newsletter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.